Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (1) , 504-508
Abstract
No abstract availableKeywords
Funding Information
- Liver Disease Prevention and Treatment Research Foundation
- Kaohsiung Research Association for the Control of Liver Disease
This publication has 20 references indexed in Scilit:
- Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis CMedicine, 2015
- Half a Diagnosis: Gap in Confirming Infection among Hepatitis C Antibody-positive PatientsThe American Journal of Medicine, 2013
- Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology, 2013
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective StudyThe Journal of Infectious Diseases, 2012
- Is Hepatitis C Virus Core Antigen an Adequate Marker for Community Screening?Journal of Clinical Microbiology, 2012
- Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–2Gut, 2010
- Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based StudyThe Kaohsiung Journal of Medical Sciences, 2010
- Treatment of chronic hepatitis C in Asia: When East meets WestJournal of Gastroenterology and Hepatology, 2009
- Viral RNA Testing in Hepatitis C Antibody–Positive VeteransAmerican Journal of Preventive Medicine, 2009
- Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening ParticipantsJournal of the Formosan Medical Association, 2007